Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-02 8:03 pm Purchase |
2022-10-25 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 2,158,272 9.970% |
1,553,044 (+256.60%) |
Filing History |
| 2022-10-25 06:01 am Purchase |
2022-10-21 | 13G | Cellectar Biosciences, Inc. CLRB |
Lincoln Park Capital Fund LLC | 937,588 9.990% |
706,220 (+305.24%) |
Filing History |
| 2022-02-14 7:44 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 417,779 6.600% |
-56,621 (-11.94%) |
Filing History |
| 2022-02-14 1:58 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 0 0.000% |
-470,344 (Position Closed) |
Filing History |
| 2022-02-10 4:02 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Sio Capital Management, LLC | 0 0.000% |
-233,112 (Position Closed) |
Filing History |
| 2022-01-21 3:49 pm Purchase |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 605,228 9.970% |
284,512 (+88.71%) |
Filing History |
| 2021-07-08 1:30 pm Purchase |
2021-06-30 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 320,716 6.000% |
320,716 (New Position) |
Filing History |
| 2021-02-17 3:10 pm Sale |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 470,344 9.990% |
-135,507 (-22.37%) |
Filing History |
| 2021-02-16 5:10 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Boxer Capital LLC | 184,000 4.000% |
90,824 (+97.47%) |
Filing History |
| 2021-02-16 2:20 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 605,851 9.990% |
605,851 (New Position) |
Filing History |
| 2021-02-16 1:03 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Sio Capital Management, LLC | 233,112 8.690% |
233,112 (New Position) |
Filing History |
| 2021-02-16 11:26 am Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 474,400 9.990% |
234,138 (+97.45%) |
Filing History |
| 2021-02-16 07:22 am Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
North Sound Trading, LP | 216,495 4.800% |
123,995 (+134.05%) |
Filing History |
| 2020-07-13 2:38 pm Purchase |
2020-07-11 | 13G | Cellectar Biosciences, Inc. CLRB |
Lincoln Park Capital Fund LLC | 231,368 8.920% |
231,368 (New Position) |
Filing History |
| 2020-07-10 4:15 pm Sale |
2020-06-30 | 13G | Cellectar Biosciences, Inc. CLRB |
HIRSCHMAN ORIN | 103,423 4.310% |
-53,097 (-33.92%) |
Filing History |
| 2020-06-12 4:18 pm Purchase |
2020-06-03 | 13G | Cellectar Biosciences, Inc. CLRB |
Armistice Capital, LLC | 131,962 4.990% |
131,962 (New Position) |
Filing History |
| 2020-06-12 4:09 pm Purchase |
2020-06-05 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 240,262 9.990% |
240,262 (New Position) |
Filing History |
| 2020-06-10 06:32 am Purchase |
2020-06-03 | 13G | Cellectar Biosciences, Inc. CLRB |
HIRSCHMAN ORIN | 156,520 6.520% |
156,520 (New Position) |
Filing History |